Sympathetic Repackaging: Drug Industry And Unions United To Bill To Lower Drug Prices

Labor Unions Team Up With Drug Makers To Defeat Drug-Price Proposals by Katie Thomas.  The New York Times.  December 3, 2019.

Patient Advocacy Groups Receive Millions From Drug Makers: Conflicts Of Interests?

Patient Advocacy Groups Take In Millions From Drugmakers.  Is There A Payback? by Emily Kopp, Sydney Lupkin, and Elizabeth Lucas.  Kaiser Health News.  April 6, 2018. 

Drug Maker Seeks Distance From Trump Lawyer Cohen

Novartis's Top Lawyer Is Out After Payments To Michael Cohen by Prashant S. Rao and Katie Thomas.  The New York Times.  May 16, 2018. 

Survey Of Pharma Lobbying

Drug Industry Spent Millions To Squelch Talk About High Drug Prices by Jay Hancock.  December 19, 2017. 

Conservatives Advance Campaign Against Government-Provided Veterans Medical Care

With Obamacare Fight Lost, Conservatives Turn To Veterans' Care by Nicholas Fandos.  The New York Times.  November 9, 2017. 

Medicare Lobbyist--Earnings: $400,000--Now HHS Chief Of Staff

Lobbyists, Industry Lawyers Were Granted Ethics Waivers To Work In Trump Administration by Eric Lipton and Danielle Ivory.  New York Times.  June 7, 2017. 

Major Pharmaceutical Chain Quits U.S. Chamber Of Commerce Over A Global Lobbying Campaign Against Antismoking Laws

CVS Health Quits U.S. chamber Over Stance On Smoking by Danny Hakim.  The New York Times.  July 7, 2015. 

Passing The United States in Obesity, Mexico Taxes Soda And Junk Food

Viva Mexico by Mark Bittman.  The New York Times.  November 29, 2013.

(1)  High-fructose corn syrup accounts for ________ percent of calories in the American diet.

(2)  The annual consumption of sweetened beverages in Mexico and the United States is around _________ gallons per capita.

(3)  Proponents of the tax linked its passage to assuring that purified drinking water would ________________.

(4)  The junk food tax will use _____________ to define processed foods that are detrimental to health.

(5)  Due to ______________ Mexico has suffered more than any other country by adapting the standard American diet.

Lobbying And Health Care Costs: A Case Study

Fiscal Footnote:  Big Senate Gift To Drug Makers by Eric Lipton and Kevin Sack.  The New York Times.  January 19, 2013.

The story of the lobbying effort by Amgen, the world's largest biotechnology firm, to delay price restraints for a class of kidney dialysis drugs for two years resulting in costs to Medicare of up to $500 million.